Company & Sponsor Intelligence

University of Florida

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials17

Recruiting3

Completed12

Countries1

Therapeutic footprint

alzheimersautismdementia_otherdepressionepilepsyneurodevelopmental_otherother_neurologyparkinsonssubstance_use

Indexed studies

NCT05014971Telehealth in Lewy Body Dementia
parkinsons · United StatesNA

NCT07674264Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD
parkinsons · United StatesNA

NCT02461706Treatment of Drug Resistant Epilepsy
epilepsy · United StatesNO_LONGER_AVAILABLE

NCT03359902Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation
alzheimers · United StatesNA

NCT04477161Effect of Ketone Esters in Parkinson's Disease
parkinsons · United StatesNA

NCT05201703Fycompa in Catamenial Epilepsy
epilepsy · United StatesPHASE4

NCT02453763In Vivo Imaging of Therapeutic Electric Current Flow
alzheimers · United StatesCOMPLETED

NCT04829656The PACE-DLB Study
dementia_other · United StatesCOMPLETED

NCT04795908Combined CBIT and rTMS to Improve Tourette's Syndrome
neurodevelopmental_other · United StatesNA

NCT06688357Revitalize Cognition: Near Infrared Stimulation in Parkinson Patients
parkinsons · United StatesNA

NCT04836715Prevalence of Visual Dysfunction in Neurological Disorders
parkinsons · United StatesCOMPLETED

NCT00360009Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease
parkinsons · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →